Male infertility treatments: clinical overview
The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
I. A. Korneev [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Медицинский совет - Remedium Group LLC, 2019, (2019), 13, Seite 99-104 |
|---|---|
| Übergeordnetes Werk: |
year:2019 ; number:13 ; pages:99-104 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.21518/2079-701X-2019-13-99-104 |
|---|
| Katalog-ID: |
DOAJ02323993X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ02323993X | ||
| 003 | DE-627 | ||
| 005 | 20230505014203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2019 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.21518/2079-701X-2019-13-99-104 |2 doi | |
| 035 | |a (DE-627)DOAJ02323993X | ||
| 035 | |a (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a I. A. Korneev |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Male infertility treatments: clinical overview |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. | ||
| 650 | 4 | |a male infertility | |
| 650 | 4 | |a idiopathic infertility | |
| 650 | 4 | |a pathozoospermia | |
| 650 | 4 | |a antioxidant therapy | |
| 650 | 4 | |a androdoz | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 773 | 0 | 8 | |i In |t Медицинский совет |d Remedium Group LLC, 2019 |g (2019), 13, Seite 99-104 |w (DE-627)1760607460 |x 26585790 |7 nnns |
| 773 | 1 | 8 | |g year:2019 |g number:13 |g pages:99-104 |
| 856 | 4 | 0 | |u https://doi.org/10.21518/2079-701X-2019-13-99-104 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.med-sovet.pro/jour/article/view/3977 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2079-701X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5790 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2019 |e 13 |h 99-104 | ||
| author_variant |
i a k iak |
|---|---|
| matchkey_str |
article:26585790:2019----::aenetlttetetcii |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.21518/2079-701X-2019-13-99-104 doi (DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 DE-627 ger DE-627 rakwb rus I. A. Korneev verfasserin aut Male infertility treatments: clinical overview 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R In Медицинский совет Remedium Group LLC, 2019 (2019), 13, Seite 99-104 (DE-627)1760607460 26585790 nnns year:2019 number:13 pages:99-104 https://doi.org/10.21518/2079-701X-2019-13-99-104 kostenfrei https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 kostenfrei https://www.med-sovet.pro/jour/article/view/3977 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 13 99-104 |
| spelling |
10.21518/2079-701X-2019-13-99-104 doi (DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 DE-627 ger DE-627 rakwb rus I. A. Korneev verfasserin aut Male infertility treatments: clinical overview 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R In Медицинский совет Remedium Group LLC, 2019 (2019), 13, Seite 99-104 (DE-627)1760607460 26585790 nnns year:2019 number:13 pages:99-104 https://doi.org/10.21518/2079-701X-2019-13-99-104 kostenfrei https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 kostenfrei https://www.med-sovet.pro/jour/article/view/3977 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 13 99-104 |
| allfields_unstemmed |
10.21518/2079-701X-2019-13-99-104 doi (DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 DE-627 ger DE-627 rakwb rus I. A. Korneev verfasserin aut Male infertility treatments: clinical overview 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R In Медицинский совет Remedium Group LLC, 2019 (2019), 13, Seite 99-104 (DE-627)1760607460 26585790 nnns year:2019 number:13 pages:99-104 https://doi.org/10.21518/2079-701X-2019-13-99-104 kostenfrei https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 kostenfrei https://www.med-sovet.pro/jour/article/view/3977 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 13 99-104 |
| allfieldsGer |
10.21518/2079-701X-2019-13-99-104 doi (DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 DE-627 ger DE-627 rakwb rus I. A. Korneev verfasserin aut Male infertility treatments: clinical overview 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R In Медицинский совет Remedium Group LLC, 2019 (2019), 13, Seite 99-104 (DE-627)1760607460 26585790 nnns year:2019 number:13 pages:99-104 https://doi.org/10.21518/2079-701X-2019-13-99-104 kostenfrei https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 kostenfrei https://www.med-sovet.pro/jour/article/view/3977 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 13 99-104 |
| allfieldsSound |
10.21518/2079-701X-2019-13-99-104 doi (DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 DE-627 ger DE-627 rakwb rus I. A. Korneev verfasserin aut Male infertility treatments: clinical overview 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R In Медицинский совет Remedium Group LLC, 2019 (2019), 13, Seite 99-104 (DE-627)1760607460 26585790 nnns year:2019 number:13 pages:99-104 https://doi.org/10.21518/2079-701X-2019-13-99-104 kostenfrei https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 kostenfrei https://www.med-sovet.pro/jour/article/view/3977 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2019 13 99-104 |
| language |
Russian |
| source |
In Медицинский совет (2019), 13, Seite 99-104 year:2019 number:13 pages:99-104 |
| sourceStr |
In Медицинский совет (2019), 13, Seite 99-104 year:2019 number:13 pages:99-104 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Медицинский совет |
| authorswithroles_txt_mv |
I. A. Korneev @@aut@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
1760607460 |
| id |
DOAJ02323993X |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ02323993X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014203.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2019-13-99-104</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ02323993X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">I. A. Korneev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Male infertility treatments: clinical overview</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">male infertility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">idiopathic infertility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pathozoospermia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antioxidant therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">androdoz</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2019), 13, Seite 99-104</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">number:13</subfield><subfield code="g">pages:99-104</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2019-13-99-104</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/3977</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="e">13</subfield><subfield code="h">99-104</subfield></datafield></record></collection>
|
| author |
I. A. Korneev |
| spellingShingle |
I. A. Korneev misc male infertility misc idiopathic infertility misc pathozoospermia misc antioxidant therapy misc androdoz misc Medicine misc R Male infertility treatments: clinical overview |
| authorStr |
I. A. Korneev |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760607460 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
26585790 |
| topic_title |
Male infertility treatments: clinical overview male infertility idiopathic infertility pathozoospermia antioxidant therapy androdoz |
| topic |
misc male infertility misc idiopathic infertility misc pathozoospermia misc antioxidant therapy misc androdoz misc Medicine misc R |
| topic_unstemmed |
misc male infertility misc idiopathic infertility misc pathozoospermia misc antioxidant therapy misc androdoz misc Medicine misc R |
| topic_browse |
misc male infertility misc idiopathic infertility misc pathozoospermia misc antioxidant therapy misc androdoz misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Медицинский совет |
| hierarchy_parent_id |
1760607460 |
| hierarchy_top_title |
Медицинский совет |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760607460 |
| title |
Male infertility treatments: clinical overview |
| ctrlnum |
(DE-627)DOAJ02323993X (DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7 |
| title_full |
Male infertility treatments: clinical overview |
| author_sort |
I. A. Korneev |
| journal |
Медицинский совет |
| journalStr |
Медицинский совет |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
txt |
| container_start_page |
99 |
| author_browse |
I. A. Korneev |
| format_se |
Elektronische Aufsätze |
| author-letter |
I. A. Korneev |
| doi_str_mv |
10.21518/2079-701X-2019-13-99-104 |
| title_sort |
male infertility treatments: clinical overview |
| title_auth |
Male infertility treatments: clinical overview |
| abstract |
The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. |
| abstractGer |
The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. |
| abstract_unstemmed |
The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
13 |
| title_short |
Male infertility treatments: clinical overview |
| url |
https://doi.org/10.21518/2079-701X-2019-13-99-104 https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7 https://www.med-sovet.pro/jour/article/view/3977 https://doaj.org/toc/2079-701X https://doaj.org/toc/2658-5790 |
| remote_bool |
true |
| ppnlink |
1760607460 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.21518/2079-701X-2019-13-99-104 |
| up_date |
2024-07-03T16:30:57.597Z |
| _version_ |
1803576155940323328 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ02323993X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014203.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2019 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2019-13-99-104</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ02323993X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJaeb637dd3b2441ebb9ed889b0ad01ed7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">I. A. Korneev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Male infertility treatments: clinical overview</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">male infertility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">idiopathic infertility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pathozoospermia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antioxidant therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">androdoz</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2019), 13, Seite 99-104</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2019</subfield><subfield code="g">number:13</subfield><subfield code="g">pages:99-104</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2019-13-99-104</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/aeb637dd3b2441ebb9ed889b0ad01ed7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/3977</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2019</subfield><subfield code="e">13</subfield><subfield code="h">99-104</subfield></datafield></record></collection>
|
| score |
7.400687 |